Zeinab Fallah
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Zeinab Fallah has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
Arman Khani
Control Engineering Department, Faculty of Electrical and Computer Engineering University of Tabriz Tabriz Iran
1 shared publication- Behnam Dalfardi
Endocrinology and Metabolism Research Center, Institute of Basic and Clinical Physiology Sciences, Kerman University of Medical Sciences, Kerman, Iran
1 shared publication Farzad Hashemzadeh
Faculty of Electrical and Computer Engineering, University of Tabriz, Iran
1 shared publication- Gholamreza Sepehri
Neuroscience Research Center, Kerman University of Medical Sciences, Kerman, Iran
1 shared publication Hamed Kharrati
Faculty of Electrical and Computer Engineering, University of Tabriz, Iran
1 shared publication- Hamid Daneshvar
Immunology Department, Faculty of Medicine, Kerman University of Medical Sciences, Kerman, Iran
1 shared publication
Latest Publications
- 19 May 2025
- Published by Wiley in Optimal Control Applications and Methods
- Vol. 46 (5) , 2095-2107
Type 1 Diabetes Control Using Type 3 Fuzzy Fault Tolerant Predictive Control
This article presents the regulation of blood glucose levels using a type 3 fuzzy predictive controller in type 1 diabetic patients in the presence of sensor faults. The proposed structure includes an on‐line fuzzy identification system, a predictive controller based on the fuzzy identification system, an adaptive compensator, and a sensor fault compensator structure. The final controller is obtained from the sum of the main controller and the output control signal of the fault detection unit. In the dynamics of type 1 diabetes, glucose is unknown; so in this article it is estimated on‐line by type 3 fuzzy systems. To ensure the stability of the closed‐loop system, Lyapunov stability analysis is used to design the adaptive compensator. The proposed methodology is evaluated based on Bergman's modified model under disturbances and various parametric uncertainties for different virtual subjects.
- 19 May 2025
- Published by Wiley in Optimal Control Applications and Methods
- Vol. 46 (5) , 2095-2107
Type 1 Diabetes Control Using Type 3 Fuzzy Fault Tolerant Predictive Control
This article presents the regulation of blood glucose levels using a type 3 fuzzy predictive controller in type 1 diabetic patients in the presence of sensor faults. The proposed structure includes an on‐line fuzzy identification system, a predictive controller based on the fuzzy identification system, an adaptive compensator, and a sensor fault compensator structure. The final controller is obtained from the sum of the main controller and the output control signal of the fault detection unit. In the dynamics of type 1 diabetes, glucose is unknown; so in this article it is estimated on‐line by type 3 fuzzy systems. To ensure the stability of the closed‐loop system, Lyapunov stability analysis is used to design the adaptive compensator. The proposed methodology is evaluated based on Bergman's modified model under disturbances and various parametric uncertainties for different virtual subjects.
- Open Access
- 30 October 2024
- Published by Maad Rayan Publishing Company in Journal of Kerman University of Medical Sciences
- Vol. 31 (5) , 259-265
Dexamethasone Treatment Considerably Reduces the Levels of Some Inflammatory Cytokines, Lactate Dehydrogenase, and C-Reactive Protein in COVID-19 Pneumonia Patients With Pre-existing COPD
Background: Dexamethasone is the most widely used corticosteroid for treating COVID-19 pulmonary complications. The effects of dexamethasone on serum inflammatory factors, including C-reactive protein (CRP), lactate dehydrogenase (LDH), and cortisol, were evaluated in COVID-19 pneumonia patients with pre-existing chronic obstructive pulmonary disease (COPD) in this study. Methods: A total of 36 COVID-19 patients with pneumonia who had pre-existing COPD and were critically ill and 56 COVID-19- positive patients without pre-existing COPD were selected. A daily dose of 6–8 mg dexamethasone was administered during the hospitalization period. Some inflammatory markers (TNF-α, IL-10, and IL-6) and the serum levels of cortisol, LDH, and CRP were measured on admission and one week after hospitalization. Results: TNF-α and IL-6 concentrations were significantly reduced and IL-10 significantly increased in all COVID-19 pneumonia patients with or without pre-existing COPD as a result of a daily dose of dexamethasone. Also, a significant reduction in cortisol, CRP, and LDH was observed following dexamethasone administration in all COVID-19 pneumonia patients, with or without preexisting COPD, with no correlation with gender, cigarette or waterpipe smoking, or opium abuse. Conclusion: Our results showed a significant increase in TNF-α, IL-6, IL-10, cortisol, LDH, and CRP and a significant reduction in IL-10 in all critically ill COVID-19 pneumonia patients. Dexamethasone administration significantly reduced cortisol and proinflammatory cytokines and also LDH and CRP as the markers of COVID-19 severity.
- 30 October 2024
- Published by Maad Rayan Publishing Company in Journal of Kerman University of Medical Sciences
- Vol. 31 (5) , 259-265
Open AccessDexamethasone Treatment Considerably Reduces the Levels of Some Inflammatory Cytokines, Lactate Dehydrogenase, and C-Reactive Protein in COVID-19 Pneumonia Patients With Pre-existing COPD
Background: Dexamethasone is the most widely used corticosteroid for treating COVID-19 pulmonary complications. The effects of dexamethasone on serum inflammatory factors, including C-reactive protein (CRP), lactate dehydrogenase (LDH), and cortisol, were evaluated in COVID-19 pneumonia patients with pre-existing chronic obstructive pulmonary disease (COPD) in this study. Methods: A total of 36 COVID-19 patients with pneumonia who had pre-existing COPD and were critically ill and 56 COVID-19- positive patients without pre-existing COPD were selected. A daily dose of 6–8 mg dexamethasone was administered during the hospitalization period. Some inflammatory markers (TNF-α, IL-10, and IL-6) and the serum levels of cortisol, LDH, and CRP were measured on admission and one week after hospitalization. Results: TNF-α and IL-6 concentrations were significantly reduced and IL-10 significantly increased in all COVID-19 pneumonia patients with or without pre-existing COPD as a result of a daily dose of dexamethasone. Also, a significant reduction in cortisol, CRP, and LDH was observed following dexamethasone administration in all COVID-19 pneumonia patients, with or without preexisting COPD, with no correlation with gender, cigarette or waterpipe smoking, or opium abuse. Conclusion: Our results showed a significant increase in TNF-α, IL-6, IL-10, cortisol, LDH, and CRP and a significant reduction in IL-10 in all critically ill COVID-19 pneumonia patients. Dexamethasone administration significantly reduced cortisol and proinflammatory cytokines and also LDH and CRP as the markers of COVID-19 severity.
- 16 February 2021
- Published by SAGE Publications in Journal of Vibration and Control
- Vol. 28 (9-10) , 1187-1199
Further enhancement on H∞ sliding mode control design for singular Markovian jump systems with partly known transition probabilities
This study considers the designing of the H ∞ sliding mode controller for a singular Markovian jump system described by discrete-time state-space realization. The system under investigation is subject to both matched and mismatched external disturbances, and the transition probability matrix of the underlying Markov chain is considered to be partly available. A new sufficient condition is developed in terms of linear matrix inequalities to determine the mode-dependent parameter of the proposed quasi-sliding surface such that the stochastic admissibility with a prescribed H ∞ performance of the sliding mode dynamics is guaranteed. Furthermore, the sliding mode controller is designed to assure that the state trajectories of the system will be driven onto the quasi-sliding surface and remain in there afterward. Finally, two numerical examples are given to illustrate the effectiveness of the proposed design algorithms.
- 16 February 2021
- Published by SAGE Publications in Journal of Vibration and Control
- Vol. 28 (9-10) , 1187-1199
Further enhancement on H∞ sliding mode control design for singular Markovian jump systems with partly known transition probabilities
This study considers the designing of the H ∞ sliding mode controller for a singular Markovian jump system described by discrete-time state-space realization. The system under investigation is subject to both matched and mismatched external disturbances, and the transition probability matrix of the underlying Markov chain is considered to be partly available. A new sufficient condition is developed in terms of linear matrix inequalities to determine the mode-dependent parameter of the proposed quasi-sliding surface such that the stochastic admissibility with a prescribed H ∞ performance of the sliding mode dynamics is guaranteed. Furthermore, the sliding mode controller is designed to assure that the state trajectories of the system will be driven onto the quasi-sliding surface and remain in there afterward. Finally, two numerical examples are given to illustrate the effectiveness of the proposed design algorithms.